STOCK TITAN

Perceptive Advisors Reports 2.48M ACLX Shares; 4.5% Ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Perceptive Advisors and affiliated parties reported beneficial ownership of 2,478,000 shares of Arcellx, Inc. (ACLX), representing 4.5% of the outstanding common stock based on 55,458,912 shares outstanding as of August 1, 2025. The filing shows the Master Fund directly holds the 2,478,000 shares, with Perceptive Advisors serving as investment manager and Joseph Edelman identified as managing member. All three reporting persons report shared voting and dispositive power over those shares and report no sole voting or dispositive power. The Schedule 13G/A is filed under the passive investor framework and contains standard certifications and signatures by Joseph Edelman.

Positive

  • Clear disclosure of beneficial ownership amounting to 2,478,000 shares and the basis for the percentage calculation
  • Identification of relationship between Perceptive Advisors, the Master Fund, and Joseph Edelman clarifies control and manager roles

Negative

  • None.

Insights

TL;DR: A well-documented passive 4.5% stake is disclosed, below the 5% threshold and unlikely to change control dynamics.

The Schedule 13G/A discloses a 4.5% beneficial ownership position in Arcellx by Perceptive Advisors, its Master Fund, and Joseph Edelman. The position is reported as shared voting and dispositive power, with no sole control. Because the filing uses Schedule 13G/A language consistent with passive investment reporting and the stake is under 5% of the float, this disclosure is informational and indicates monitoring interest rather than an active control campaign. The filing references the issuer share count used to calculate percentage, ensuring the ownership percentage is transparent.

TL;DR: Disclosure clarifies ownership and voting arrangements but does not signal governance change.

The report attributes shared voting and dispositive power to Perceptive Advisors and Joseph Edelman for the 2,478,000 shares held by the Master Fund. This explicit identification of roles reduces ambiguity about who directs voting decisions. However, at 4.5% ownership the position remains below common thresholds that typically trigger formal governance influence or mandatory takeover filings. The filing contains standard certifications and signatures, meeting regulatory disclosure obligations.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:08/14/2025
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:08/14/2025
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:08/14/2025

FAQ

What percentage of Arcellx (ACLX) does Perceptive Advisors report owning?

Perceptive Advisors and affiliated reporting persons disclose beneficial ownership of 2,478,000 shares, representing 4.5% of ACLX common stock based on 55,458,912 shares outstanding as of August 1, 2025.

Does the filing indicate Perceptive Advisors has sole voting control over ACLX shares?

No. The filing reports 0 shares with sole voting power and 2,478,000 shares with shared voting power.

Who directly holds the reported ACLX shares?

The Schedule states that Perceptive Life Sciences Master Fund, Ltd. directly holds the 2,478,000 shares, with Perceptive Advisors as investment manager and Joseph Edelman as managing member.

Was this filing made under the passive investor rules?

Yes. The Schedule 13G/A format and the reporting context indicate the position is disclosed under the passive investor framework rather than an active Section 13(d) control filing.

When was the Schedule 13G/A signed?

The signatures on the filing are dated 08/14/2025 signed by Joseph Edelman for the reporting entities.